Binghamton University, State University of New York will play a key role in a federal grant of up to $42.8 million to develop ...
News Medical on MSN11h
Binghamton University joins groundbreaking $42.8 million inflammatory disease treatment projectBinghamton University will play a key role in a federal grant of up to $42.8 million to develop an implantable device that acts as a living pharmacy to treat inflammatory diseases.
In a world first, researchers at the Kennedy Institute, Oxford have mapped the cellular dynamics following treatment with the ...
Breastfeeding, child nutrition and exposure to secondhand tobacco smoke at an early age may play a role in the onset of ...
Half a million people across the UK, of whom I am one, live day in day out with Inflammatory Bowel Disease (IBD). IBD is a ...
The study emphasises on the role of the p53 tumor suppressor gene in the pathogenesis of ulcerative colitis - an inflammatory ...
Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering ...
The use of glucagon-like peptide 1 (GLP-1) agonists in patients with inflammatory bowel disease (IBD) was associated with few ...
CNW/ - A research team led by Professor Marie-Claude Rousseau of the Institut national de la recherche scientifique (INRS) ...
Crohn’s disease is a type of inflammatory bowel disease (IBD) that involves periods of remission and flares. Symptoms can ...
SYMPTOMS of bowel cancer can be both subtle or embarrassing to discuss with a GP, as they can affect your bowel habits. But ...
A research team led by Professor Marie-Claude Rousseau of the Institut national de la recherche scientifique (INRS) and Dr. Prévost Jantchou ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback